Asia Green Biotechnology Corp. Closes Financing To Proceed With Research Activities
01/11/22, 8:25 PM
Location
calgary
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announced today that it has closed the previously announced financing arrangement with a director of the Company. The funds raised under this arrangement will be used for the purpose of addressing certain expenses tied to ongoing research activities being conducted or which may be commenced by the Company pursuant to the terms of its technology licensing agreements with InPlanta Biotechnology Ltd. ("InPlanta"), Pathway RX Inc
Company Info
Location
calgary, alberta, canada
Additional Info
Asia Green is an early-stage international bio-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of license agreements with InPlanta, Swysh and Pathway.